Los Angeles, CA, United States of America

Ka Man Law

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ka Man Law in Colorectal Cancer Research

Introduction

Ka Man Law is an accomplished inventor based in Los Angeles, CA. She has made significant contributions to the field of medical research, particularly in the area of colorectal cancer and inflammatory bowel disease (IBD). Her innovative work focuses on the regulation of tumor formation through micro RNA.

Latest Patents

Ka Man Law holds a patent titled "Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling." This application discloses methods for treating, preventing, and diagnosing colorectal cancer and IBD. The methods involve administering an effective dose of antisense miR-133α or AFTPH to the subject or detecting expression levels of miR-133α and AFTPH.

Career Highlights

Ka Man Law is affiliated with the University of California, where she conducts her research. Her work has garnered attention for its potential impact on cancer treatment and diagnosis. With a focus on innovative solutions, she continues to advance the understanding of tumor biology.

Collaborations

Ka Man Law collaborates with esteemed colleagues, including Dimitrios Iliopoulos and Charalabos Pothoulakis. These partnerships enhance her research efforts and contribute to the development of new therapeutic strategies.

Conclusion

Ka Man Law's contributions to colorectal cancer research exemplify the importance of innovation in medical science. Her patent and ongoing work hold promise for improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…